Cargando…
Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma
BACKGROUND: The challenging diagnosis and poor prognosis of cholangiocarcinoma require the determination of biomarkers. Autoantibodies could be used in the clinic as diagnostic markers for the early detection of tumours. By proteomic approaches, several autoantibodies were proposed as potential mark...
Autores principales: | Mustafa, Mohammad Zahid, Nguyen, Viet Hung, Le Naour, François, De Martin, Eleonora, Beleoken, Elvire, Guettier, Catherine, Johanet, Catherine, Samuel, Didier, Duclos-Vallee, Jean-Charles, Ballot, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715332/ https://www.ncbi.nlm.nih.gov/pubmed/26774260 http://dx.doi.org/10.1186/s12967-015-0751-2 |
Ejemplares similares
-
SPRi-Based Strategy to Identify Specific Biomarkers in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Autoimmune Hepatitis
por: Beleoken, Elvire, et al.
Publicado: (2013) -
Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma
por: Dalmasso, Cyril, et al.
Publicado: (2015) -
Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
por: Chiappini, Franck, et al.
Publicado: (2017) -
Serological Technique: Immuno-Therapy (Contd.). Antibacterial Sera
por: Greval, S. D. S.
Publicado: (1951) -
Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis
por: Fernández Madrid, Félix, et al.
Publicado: (2015)